Total Neoadjuvant Therapy for All Rectal Cancers: Is This the Way Ahead of the OPRA Trial?

Free first page© 2022 by American Society of Clinical Oncology

The data that support the findings of this study are available on request from the corresponding author on reasonable request. The data are not publicly available due to privacy or ethical restrictions.

AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST

Total Neoadjuvant Therapy for All Rectal Cancers: Is This the Way Ahead of the OPRA Trial?

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/authors/author-center.

Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).

No potential conflicts of interest were reported.

留言 (0)

沒有登入
gif